Application of Nanoliposome Alprostadil in the Perioperative Period of Percutaneous Coronary Intervention to Reduce In-Stent Restenosis: A Systematic Review and Meta-Analysis

BACKGROUND: In-stent restenosis (ISR) is a common complication after percutaneous coronary intervention (PCI) surgery for patients with coronary atherosclerotic heart disease (CHD). Reports indicate alprostadil may reduce ISR, and this study aimed at reviewing and summarizing the effect of nanolipos...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Decai, Wang, Dawei, Zhao, Zhen, Liu, Qingqing, Yang, Rongyuan, Liu, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212678/
https://www.ncbi.nlm.nih.gov/pubmed/37251365
http://dx.doi.org/10.1155/2023/4100197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212678/
https://www.ncbi.nlm.nih.gov/pubmed/37251365
http://dx.doi.org/10.1155/2023/4100197

Ejemplares similares